Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic Website Promotes Activa For Off-Label Uses - FDA Warning Letter

This article was originally published in The Gray Sheet

Executive Summary

Medtronic and FDA are continuing discussions about appropriate disclaimers for promotional material on the firm's website related to uses of its Activa tremor control system that are not yet approved in the U.S., following receipt of a March 23 warning letter.

You may also be interested in...



Medtronic Activa Postmarket Study On Parkinson’s Will Begin By Summer

Medtronic's 230-patient, three-year post-approval study of its Activa Parkinson's disease neurostimulation therapy will begin enrollment by this summer

Medtronic Activa Postmarket Study On Parkinson’s Will Begin By Summer

Medtronic's 230-patient, three-year post-approval study of its Activa Parkinson's disease neurostimulation therapy will begin enrollment by this summer

Internet Promotion Warning Letters Continue In Guidance Vacuum

Counsel for OmniCorder Technologies is preparing a response to an April 18 warning letter citing Internet promotions representing the firm's BioScan system "as a stand-alone diagnostic device for breast cancer detection," the company says.

Related Content

UsernamePublicRestriction

Register

MT013222

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel